Our lab is thrilled to announce that Cao Chenyu has successfully passed her PhD defense on June 18, 2024. Dr. Cao Chenyu’s dedication and hard work have led to significant advancements in our understanding of the multifunctional protein isthmin-1 (ISM1) and its various biological roles.
Chenyu’s research focused on ISM1, a protein known for its anti-angiogenic, anti-tumorigenic, anti-inflammatory, and pro-apoptotic properties. Her work has provided new insights into how ISM1 interacts with its receptor, cell surface GRP78 (csGRP78), and the subsequent cellular processes it influences. In addition to exploring ISM1’s role in apoptosis, Chenyu investigated its potential effects on cellular senescence, particularly in lung diseases. Her findings have opened new avenues for understanding the complex mechanisms by which ISM1 may contribute to cellular health and disease.
We are incredibly proud of Chenyu’s achievements and her contributions to the field. Her research not only enhances our knowledge of ISM1 but also lays the groundwork for potential future therapeutic applications targeting lung diseases.
As Chenyu continues her scientific journey, we look forward to her ongoing research and the impact she will undoubtedly make in the scientific community. Please join us in congratulating Dr. Cao on this significant milestone.
